Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12148L |
N-Desmethyltamoxifen
|
Others | Others |
N-Desmethyltamoxifen, the principal metabolite of tamoxifen in humans, serves as an efficacious modulator of ceramide metabolism within human AML cells by inhibiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation. Although it demonstrates weak antiestrogenic properties, it acts as a protein kinase C (PKC) inhibitor with a potency ten times greater than that of tamoxifen. | |||
T12148 |
N-Desmethyltamoxifen hydrochloride
|
Estrogen Receptor/ERR; Endogenous Metabolite; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; Endocrinology/Hormones; Metabolism |
N-Desmethyltamoxifen hydrochloride 是 Tamoxifen 在人体内主要的三苯氧胺代谢物。它是蛋白激酶 C 抑制剂,也是人体 AML 细胞神经酰胺代谢的有效调节因子,可限制神经酰胺糖基化、水解和鞘氨醇磷酸化。 | |||
T71576 |
SIM010603
|
||
SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM010603 inhibited stem cell factor receptor (Kit), vascular endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factor receptor-β (PDGFR-β), glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), and Fms-like tyrosine kinase-3 (FLT3) with IC(50) values between 5.0 and 68.1 nmol/l. SIM010603 inhibited the phosphorylation of PDGFR-β and VEGFR-2. Mor... |